Litigation
Protiva Biotherapeutics, Inc. et al. v. Moderna Therapeutics, Inc. et al.
affirmed; concluded2020-1183
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2019-11-27
- Terminated
- 2023-04-11
Patents at issue (1)
Plaintiffs (2)
Defendants (2)
Summary
Appeal from IPR2018-00680. The Federal Circuit affirmed the PTAB's final written decision holding all claims of US 9,404,127 unpatentable as inherently anticipated, resulting in cancellation of the '127 claims.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).